Related Experiment Video
Updated: Oct 5, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
The von Hippel-Lindau gene product inhibits renal cell apoptosis via Bcl-2-dependent pathways
P Devarajan1, M De Leon, F Talasazan
1Department of Pediatrics, Division of Pediatric Nephrology, Albert Einstein College of Medicine, Bronx, New York 10461, USA. pdevaraj@aecom.yu.edu
Abstract:
Previous studies have reported a protective role for the von Hippel-Lindau (VHL) gene products against pro-apoptotic cellular stresses, but the mechanisms remain unclear. In this study, we examined the role of VHL in renal cells subjected to chemical hypoxia, using four VHL-negative and two VHL-positive cell lines. VHL-negative renal carcinoma cells underwent apoptosis following chemical hypoxia (short-term glucose deprivation and antimycin treatment), as evidenced by morphologic changes and internucleosomal DNA cleavage. Reintroduction of VHL expression prevented this apoptosis. VHL-negative cells displayed a significant (greater than 5-fold) activation of caspase 9 and release of cytochrome c into the cytosol following chemical hypoxia. In contrast, VHL-positive cells showed minimal caspase 9 activation, and absence of cytochrome c release under the same conditions. Caspase 8 was only minimally activated in both VHL-negative and -positive cells. In addition, VHL-positive cells displayed a striking up-regulation of Bcl-2 expression (5-fold) following chemical hypoxia. Antisense oligonucleotides to Bcl-2 significantly down-regulated Bcl-2 protein expression in VHL-positive cells and rendered them sensitive to apoptosis. Overexpression of Bcl-2 in VHL-negative cells conferred resistance to apoptosis. Our results suggest that VHL protects renal cells from apoptosis via Bcl-2-dependent pathways.
Insights
The von Hippel-Lindau (VHL) gene product protects kidney cells from apoptosis during chemical hypoxia. This protection is mediated by the Bcl-2 protein, highlighting a novel therapeutic target.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The von Hippel-Lindau (VHL) gene is known to have a protective role against apoptosis.
- The precise mechanisms underlying VHL's anti-apoptotic function remain largely unelucidated.
- Renal cells are susceptible to apoptosis under conditions of chemical hypoxia.
Purpose of the Study:
- To investigate the role of VHL in renal cell apoptosis induced by chemical hypoxia.
- To elucidate the molecular pathways involved in VHL-mediated protection against apoptosis.
Main Methods:
- Utilized four VHL-negative and two VHL-positive renal carcinoma cell lines.
- Subjected cells to chemical hypoxia (glucose deprivation and antimycin).
- Assessed apoptosis through morphological changes and DNA fragmentation; analyzed caspase activation, cytochrome c release, and Bcl-2 expression.
Main Results:
- VHL-negative cells underwent apoptosis with significant caspase 9 activation and cytochrome c release upon chemical hypoxia.
- Reintroduction of VHL expression or Bcl-2 overexpression conferred resistance to apoptosis.
- VHL-positive cells exhibited minimal caspase activation and cytochrome c release, alongside a 5-fold increase in Bcl-2 expression.
Conclusions:
- VHL protects renal cells from apoptosis during chemical hypoxia.
- This protective effect is mediated through Bcl-2-dependent pathways.
- VHL's role in regulating Bcl-2 offers potential therapeutic strategies for renal cell carcinoma.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Abnormal Proliferation